Capital Numbers Infotech Limited is set to launch its IPO from January 20, 2025, to January 22, 2025, as a Book Built Issue. The company aims to raise ₹169.37 crores, comprising a fresh issue of ₹84.69 crores and an offer for sale (OFS) of 32,20,000 equity shares with a face value of ₹10 each. The IPO price band is set at ₹250 to ₹263 per share, with retail investors allotted 35%, Qualified Institutional Buyers (QIBs) 50%, and Non-Institutional Investors (HNIs) 15%. The IPO allotment date is January 23, 2025, and the shares will be listed on the BSE on January 27, 2025. Financially, the company reported revenue growth from ₹92.98 crores in FY 2023 to ₹100.39 crores in FY 2024, marking a 7.97% increase, while profits rose significantly from ₹17.35 crores to ₹25.99 crores, reflecting a 49.78% growth. With strong financials and consistent growth, the IPO presents a promising long-term investment opportunity.
Capital Numbers Infotech is a leading digital consulting and IT engineering company that delivers top-notch software development solutions to enterprises and startups worldwide. The company offers a wide range of advanced technological services, including Digital Engineering, Data Analytics, Artificial Intelligence/Machine Learning (AI/ML), Cloud Engineering, UI/UX Design, Blockchain, and Augmented Reality/Virtual Reality (AR/VR). With a team of over 500 skilled IT professionals and consultants, Capital Numbers serves more than 250 clients across various locations in India and beyond. The team specializes in Cloud, Mobile, DevOps, and Data Engineering, as well as Application Development, leveraging cutting-edge technologies and frameworks like React, Angular, .NET, Python, Node, PHP, and Java to deliver innovative and high-quality solutions.
Amount ₹ in Crores
ROCE (Return on Capital Employed):
RoNW (Return on Net Worth):
PAT Margin (Profit After Tax Margin):
Price to Book Value (P/B Ratio):
Asset Growth:
Revenue Trends:
Profitability:
Net Worth & Reserves:
Debt Levels:
The company demonstrates strong financial health with impressive profitability metrics, consistent asset growth, and increasing net worth. The low borrowing levels and high return ratios (ROCE and RoNW) reinforce the company’s efficient operations and strong market positioning.